Easton Pharmaceuticals, Inc. (EAPH)

[tardelli007]

Revenues are ramping up and will only keep growing. This doesn't include IBliss acquisition which EAPH said they updated. Everything is moving forward and shows how undervalued this company is.

Bayer Pharmaceuticals deal is short at hand for 3rd product launch.

As I've stated many times before, don't listen to anyone on here with their own agendas. Do your own due diligence, which means look at the companies press releases and contact the company by email to get accurate information. Today's press release is proof that they are moving forward positively on all fronts. Evan Karras is doing a great job as CEO with many other quality announcement soon to follow.

The stock will soon be at $.15. But don't look at $.15 or 15 times your money. Where else can you double your investment from where it is now which is a conservative number.

GO EAPH GO.